Patient Note — 171112

progress_notes_171112_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID171112 (PHI redacted)
Age / Gender— / —
Date of Service2026-01-23
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Manassas
PayerCigna Open Access Plus
Reason1. 3 MONTH F/U

Diagnoses

R97.20 Elevated PSA
N40.0 Benign prostatic hyperplasia without urinary obstruction
R31.0 Gross hematuria
N52.9 Erectile dysfunction, unspecified erectile dysfunction type

Medications

Finasteride Diclofenac Sodium Cyclobenzaprine HCl HYDROcodone-Acetaminophen 7.5-325 MG Tablet Oral Carvedilol Valsartan-hydroCHLOROthiazide 320-25 MG Tablet Oral Atorvastatin Calcium hydrALAZINE HCl Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day Progress Note: [PROVIDER_NAME], MD 01/23/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:33 AM EDT 1/4 4/16/26, 12:34 AM Print Preview [PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 01/23/2026 Tadalafil Cialis(Tadalafil) metFORMIN HCl ER Meloxicam Medication List reviewed and reconciled with the patient

Past Medical History

  • Mixed hyperlipidemia
  • Essential (primary) hypertension
  • Type 2 diabetes mellitus with unspecified complications
  • Elevated prostate specific antigen (PSA)

Vitals

RR 18.0
HR 84.0
BP 130/82
BMI 31.01
WEIGHT 204 lbs
HEIGHT_IN 68.0

Clinical Summary (HPI)

General Urology: [AGE] yM with hx of ED, BPH and elevated PSA presents today for 3-month FU. He reports an episode of hematuira. No dysuria. He does notes his symptoms are slowing worsening. on finasteride and Flomax. ========================= Prior hx: He denies dysuria, No urgency, frequency, or leaking. No GH. He is off finasteride. Is not sexually active. [ADDRESS] Arnold about 8-10 yrs ago. ========================= The patient's past workup includes: Labs (01/2026): HbA1c 6.4, Cr 1.27, CMP wnl PSA: 15.5 (01/2026-On finasteride), 24.6, %F 9 (10/2025, On finasteride) 10.5 (Mar'24); 5.8 (Sep'23); 8.0 (Apr'23); 13.3 (Sep'22); 10.8 (Aug'21); 8.14 (Jul'20); 9.56 (Jan'20); 8.4 (May'19) Labs (10/2025): HbA1c 6.5 MRI Prostate (11/2024): There are no certain or identifiable findings to corrspnd with any focus of clinically significant abnormality. marked BPH with overall gland size measured at 108g US (2022): 111cc prostate volume without suspicous masses. Elevated PSA: Prior biopsy reports were negative.

Raw Note (de-identified preview)

4/16/26, 12:34 AM Print Preview [PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 01/23/2026 [PATIENT_NAME] [AGE] Y old Male, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Cigna Open Access Plus PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Manassas Structured Data: How did you hear about us? : Other; Patient's temperature : 0 01/23/2026 Progress Notes: [PROVIDER_NAME], MD Reason for Appointment 1. 3 MONTH F/U History of Present Illness General Urology: [AGE] yM with hx of ED, BPH and elevated PSA presents today for 3-month FU. He reports an episode of hematuira. No dysuria. He does notes his symptoms are slowing worsening. on finasteride and Flomax. ========================= Prior hx: He denies dysuria, No urgency, frequency, or leaking. No GH. He is off finasteride. Is not sexually active. [ADDRESS] Arnold about 8-10 yrs ago. ========================= The patient's past workup includes: Labs (01/2026): HbA1c 6.4, Cr 1.27, CMP wnl PSA: 15.5 (01/2026-On finasteride), 24.6, %F 9 (10/2025, On finasteride) 10.5 (Mar'24); 5.8 (Sep'23); 8.0 (Apr'23); 13.3 (Sep'22); 10.8 (Aug'21); 8.14 (Jul'20); 9.56 (Jan'20); 8.4 (May'19) Labs (10/2025): HbA1c 6.5 MRI Prostate (11/2024): There are no certain or identifiable findings to corrspnd with any focus of clinically significant abnormality. marked BPH with overall gland size measured at 108g US (2022): 111cc prostate volume without suspicous masses. Elevated PSA: Prior biopsy reports were negative. Current Medications Taking Finasteride 5 MG Tablet 1 tablet Orally Once a day Diclofenac Sodium 75 MG Tablet Delayed Release Oral Cyclobenzaprine HCl 10 MG Tablet Oral HYDROcodone-Acetaminophen 7.5-325 MG Tablet Oral Carvedilol 25 MG Tablet Oral Valsartan-hydroCHLOROthiazide 320-25 MG Tablet Oral Atorvastatin Calcium 80 MG Tablet Oral hydrALAZINE HCl 50 MG Tablet Oral Finasteride 5 MG Tablet 1 tab(s) orally once a day Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day Progress Note: [PROVIDER_NAME], MD 01/23/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:33 AM EDT 1/4 4/16/26, 12:34 AM Print Preview [PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 01/23/2026 Tadalafil 5 MG Tablet 1 tab(s) orally once a day Finasteride 5 MG Tablet 1 tab(s) orally once a day Cialis(Tadalafil) 20 MG Tablet 1 tablet as needed Orally as needed Not-Taking metFORMIN HCl ER 500 MG Tablet Extended Release 24 Hour Oral Meloxicam 15 MG Tablet Oral Medication List reviewed and reconciled with the patient Past Medical History Mixed hyperlipidemia. Essential (primary) hypertension. Type 2 diabetes mellitus with unspecified complications. Elevated prostate specific antigen (PSA). Surgical History prostate biopsy colonoscopy 4/13/2018 Family History Father: unknown Mother: unknown Social History Recreational drug